Epirubicin + Fluorouracil + Folinic Acid

The drug combination "epirubicin + fluorouracil + folinic acid" is a chemotherapy regimen used primarily in cancer treatment. This combination brings together an anthracycline antibiotic (epirubicin) with a pyrimidine antagonist (fluorouracil) and a biochemical modulator (folinic acid) to enhance therapeutic efficacy. ## Composition and Mechanism This combination works through multiple mechanisms: - **Epirubicin** is an anthracycline antibiotic that intercalates with DNA, inhibiting DNA and RNA synthesis, which leads to cell death[2]. - **Fluorouracil (5-FU)** is a pyrimidine antagonist that acts as an antimetabolite. It works through several mechanisms: competing with uracil to bind with thymidylate synthetase (resulting in decreased thymidine production and DNA synthesis), incorporating into DNA (interfering with replication), and incorporating into RNA (interfering with RNA processing and protein synthesis)[4]. - **Folinic acid** (also called leucovorin or calcium folinate) is not a chemotherapy drug itself but enhances the efficacy of fluorouracil by stabilizing the binding of fluorouracil metabolites to thymidylate synthetase[4][5]. ## Clinical Applications This combination is used to treat various types of cancer, including: - Advanced pancreatic cancer[2] - Gastrointestinal tumors[2] - Advanced breast cancer[7] In clinical studies, this combination has shown moderate activity in treating advanced pancreatic cancer, with some patients experiencing improved quality of life, including freedom from pain, improved appetite, and improved performance status compared to patients receiving only supportive care[2]. ## Administration The administration protocol may vary depending on the specific cancer being treated and the patient's condition. One example of dosing from a clinical study for advanced pancreatic cancer included: - Folinic acid: 200 mg/m²/day for 5 days - Fluorouracil: 600 mg/m²/day for 5 days - Epirubicin: 35 mg/m²/day before folinic acid-fluorouracil administration on days 1 and 2, repeated every 28 days[2] ## Side Effects Common side effects of this combination therapy include: - Myelosuppression (decreased production of blood cells) - Nausea and vomiting - Diarrhea - Alopecia (hair loss) - Mucositis (inflammation of the mucous membranes)[2] This combination represents one of several fluorouracil-based regimens used in cancer treatment, with others including FOLFIRI (folinic acid, fluorouracil, and irinotecan) and FOLFOX (folinic acid, fluorouracil, and oxaliplatin)[3][5].